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Abstract
Background: Stroke poses a growing human and economic burden in South Africa. Excess sugar consumption,
especially from sugar-sweetened beverages (SSBs), has been associated with increased obesity and stroke risk.
Research shows that price increases for SSBs can influence consumption and modelling evidence suggests that
taxing SSBs has the potential to reduce obesity and related diseases. This study estimates the potential impact
of an SSB tax on stroke-related mortality, costs and health-adjusted life years in South Africa.
Methods: A proportional multi-state life table-based model was constructed in Microsoft Excel (2010). We used
consumption data from the 2012 South African National Health and Nutrition Examination Survey, previously
published own and cross price elasticities of SSBs and energy balance equations to estimate changes in daily
energy intake and BMI arising from increased SSB prices. Stroke relative risk, and prevalent years lived with
disability estimates from the Global Burden of Disease Study and modelled disease epidemiology estimates
from a previous study, were used to estimate the effect of the BMI changes on the burden of stroke.
Results: Our model predicts that an SSB tax may avert approximately 72 000 deaths, 550 000 stroke-related
health-adjusted life years and over ZAR5 billion, (USD400 million) in health care costs over 20 years (USD296-576 million).
Over 20 years, the number of incident stroke cases may be reduced by approximately 85 000 and prevalent cases by
about 13 000.
Conclusions: Fiscal policy has the potential, as part of a multi-faceted approach, to mitigate the growing burden of
stroke in South Africa and contribute to the achievement of the target set by the Department of Health to reduce
relative premature mortality (less than 60 years) from non-communicable diseases by the year 2020.
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Background
Stroke is a major cause of disability and death world-
wide. The Global Burden of Disease Study (GBD) shows
that approximately 11.6 million cases of ischaemic stroke
(65 % in low-to-middle income countries, LMICs) and
5.3 million of haemorrhagic stroke (80 % in LMICs)
occurred worldwide in 2010. Sixty-four percent of the
disability-adjusted life years (DALYs) due to ischaemic
stroke and 86 % of DALYs due to haemorrhagic stroke
were lost in LMICs [1]. In sub-Saharan Africa (SSA),
more than 30 % of stroke patients die within the first
month, less than 60 % of patients are alive after six
months and by one year less than 50 % are still alive [2].
This global burden is projected to increase to 23 million
first-ever strokes and 7.8 million deaths by 2030 [3].
The burden is also increasing in South Africa. In 2000,
stroke (mostly haemorrhagic) was the third leading
cause of death after HIV/AIDS and ischemic heart
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disease [4]. In 2008, a modelling study showed that 75
000 new cases of stroke occurred in that year, with a
third of these being fatal within 28 days. Of the 350 000
stroke survivors, 35 % had moderate to severe disability
due to the condition [4]. An estimated 33 500 strokes
occurred in rural South Africa in 2011 [5].
Stroke poses a significant human and economic bur-
den. The total direct and indirect cost of stroke for 2008
in the United States of America (USA) was estimated at
USD65.5 billion, and 27 billion Euros in 27 European
Union countries [6]. The estimated cost of care for
stroke in SSA is USD157 per episode [2]. Direct costs
include the cost of physicians and other health profes-
sionals, acute and long-term care, medications and other
medical durables. Additional indirect costs include lost
productivity resulting from morbidity and mortality and
the costs of informal care by families and communities.
Affecting mostly the economically productive age group
especially in LMICs, stroke leaves about 65 % of its vic-
tims disabled leading to increased loss of manpower
both at individual, household and societal levels [7]
which adversely affects productivity and income, and
hampers development. It also affects social relationships
and economic status.
Hypertension is the most prevalent, independent and
modifiable risk factor for stroke at the population level
in SSA [3, 8] with over 50 % of stroke cases in South
Africa attributable to hypertension [9]. Other risk factors
for stroke include diabetes, smoking, dyslipidaemia,
obesity and heavy alcohol consumption [2]. Increasing
evidence however shows a significant link between excess
sugar consumption, especially from sugar-sweetened bev-
erages (SSBs), and risk of cardiovascular disease (CVD),
including stroke. Data from the GBD estimates show that
in 2010 approximately 184 000 deaths worldwide were
attributable to SSB consumption, with almost 25 % of
these due to CVD [10]. Further longitudinal evidence sug-
gests a positive association between SSB consumption and
increased stroke risk and mortality [11–13]. The relation-
ship between SSB consumption and stroke may be medi-
ated through weight gain and/or hypertension [14–18].
However, an independent effect may arise from the large
amounts of highly absorbable sugars found in SSBs which
contribute to high glycaemic load and may lead to inflam-
mation and cardiovascular changes [16, 19, 20].
Globally, consumption of SSBs has increased alongside
the increase in non-communicable disease (NCD) preva-
lence. Between 2005 and 2010, added sugar and sucrose-
sweetened beverage consumption increased in both
urban and rural areas in South Africa, with a corre-
sponding increase in NCD risk factors [21]. The propor-
tion of adults drinking SSBs in rural areas doubled from
2005–2010. Consumption of Coca-Cola products in
South Africa increased from 183 per person per year in
2002 to 260 products in 2012 putting South Africa in
the top ten consumers of Coca-Cola products [22].
These estimates are based on a USA eight fluid ounce
serving or 250 ml. SA Euromonitor data also show a
16 % increase in soft-drink off-trade sales from 3,620
million to 4,206 million litres between 2008 and 2013
respectively [23].
A tax on SSBs is currently being advocated by policy
makers and public health experts world-wide as an
effective tool to reduce obesity. The South African
National Department of Health (DOH), has included
this as a cost effective policy intervention as part of its
Strategic Plan for the Prevention and Control of NCDs,
2013–2017 [24]. Research shows that price changes due
to taxation or subsidies can modify consumption and
potentially lead to positive diet and weight outcomes
[25, 26]. In addition, modelling evidence suggests that
taxing SSBs has the potential to reduce obesity [27–30].
Mexico introduced a tax on SSBs in January 2014 and
observational results show an average reduction of 6 %
in the purchase of taxed SSBs during 2014 [31]. This re-
duction accelerated over the course of the year to reach
12 % by December 2014. Household SSB purchases
decreased across all socioeconomic levels although
the greatest decrease was among the lowest socioeco-
nomic group which achieved a reduction of 17 % by
the end of the year [31]. The amount of the tax was
one peso ($.07 USD) per liter, roughly equivalent to a
10 % increase in price.
As a leader in promulgating tobacco taxes, the im-
plementation of taxes on tobacco in South Africa has
resulted in an aggregate decrease in cigarette con-
sumption of 41 % and a per capita decrease of 66 %
over two decades from 1990 [32]. This evidence sug-
gests that fiscal levers, as part of a multi-pronged ap-
proach, can influence consumption. The aim of this
study was to estimate the impact of an SSB tax on the
burden of stroke in South Africa through the reduction
of SSB consumption and reduction of population mean
body mass index (BMI).
Methods
An SSB was defined as a non-alcoholic drink with added
sugar. This comprised carbonated sweetened drinks,
sweetened fruit juices and squash concentrates. The ana-
lysis method involved two steps. The first step was to
quantify the impact of a 20 % SSB tax on the population
BMI distribution through changes in consumption and
energy intake. The second step was estimating the
changes in stroke outcomes due to the tax-induced
changes in BMI distribution using a life table-based
Markov model implemented in Microsoft Excel (2010).
In the model, a reference population with the BMI dis-
tribution and disease pattern of the South African adult
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population aged 15 years and older in 2012 was com-
pared with an identical intervention population which
received the 20 % tax intervention.
Figure 1 is the schematic of the model showing the
modelling steps for the intervention population. The ref-
erence population is modelled similarly except that no
changes in BMI are incorporated since no trend in BMI
was applied. The difference in health outcomes between
the two populations is attributed to the tax.
Intervention
A tax rate of 20 % was modelled for a period of 20 years,
assuming a 100 % pass on rate. Tax rates of 10 and 20 %
have been modelled in the past, with pass on rates ran-
ging between 80 and 100 % [27–29].
Change in SSB consumption
Data from the 2012 South African National Health and
Nutrition Examination Survey (SANHANES-1), a base-
line cross-sectional survey of the SANHANES series,
were used to derive baseline consumption of SSBs, milk
and unsweetened fruit juice in adults aged 15 years and
older [33]. The procedures for data collection and for
extracting data for the model have been described else-
where [30]. Changes in consumption of SSB, milk, diet
drink and unsweetened fruit juice resulting from an in-
creased SSB price were estimated using own and cross
price elasticities previously published in a systematic re-
view and meta-analysis [26]. Price elasticity estimates
from South Africa were not available. Cross price elasti-
cities were used to estimate the replacement of SSBs
with other drinks by consumers given an SSB price in-
crease. The price elasticity estimate values and standard
deviations are shown in Additional file 1: Table S1.
Change in energy intake
Average energy density estimates for each drink category
in kilojoules were used to translate the change in SSB
consumption into change in energy intake. The energy
density of SSBs was assumed to be 1800 kilojoules (kJ)/
litre, 1340 kJ/l for unsweetened juice (both based on
calculations using several Coca-Cola products) and
2540 kJ/l for whole milk based on values given by
Parmalat South Africa [34]. Coca-Cola accounts for ap-
proximately 60 % of all off-trade soft drink sales in
South Africa [35]. In addition, personal communicator,
Dr Celeste Naude, Centre for Evidence-based Health,
Stellenbosch University, calculated the mean energy
density for an SSB to be 188 kJ per 100 ml (SD 40) using
energy density values of a sample of 90 carbonated
drinks, sports drinks, concentrates, iced teas and sweet-
ened fruit juices, obtained from the South African Med-
ical Research Council Food Data System [36] and
nutrition information provided on beverage labels. Based
on an analysis of dietary surveys in South Africa which
shows that more full cream milk is consumed per capita
than skim milk, we assumed that all milk consumed was
full cream milk [37]. The changes in energy intake for
each beverage type were summed up to give the net
change in energy intake.
Change in energy balance and BMI
A study by Swinburn et al. shows that a daily change in
energy intake of 94 kJ/day (SD 2.96) is associated with a
change in body weight of 1 kg in equilibrium for adults
[38]. We used this estimate to calculate the changes in
body weight resulting from the changes in energy intake.
Our model assumes that the population will lose weight
until a new equilibrium in line with lower energy intake
is reached [38]. Baseline BMI data for adults aged
15 years and above were extracted from the 2012 Wave
3 National Income Dynamics Study (NIDS) [39] and fit-
ted to the log-normal distribution using previously pub-
lished procedures, the log-normal distribution being
selected above the gamma distribution for better fitting
properties [30]. We used data from previous waves of
the NIDS (2008 and 2010) to estimate the change in
the standard deviation of the mean (BMI) as a function
of mean BMI to predict shifts in the BMI distribution
of the population arising from the intervention, previ-
ously published, [30].
Change in stroke incidence, prevalence and mortality
The potential impact fraction (PIF), defined as the
proportional change in disease risk due to change in
exposure to a related risk factor, was used to estimate
the change in stroke incidence resulting from shifts in
BMI [40]. The Excel add-in JanB [41], which calculates





Step 2 Relative risks
Life table
20% SSB tax
Change in body weight
Change in stroke incidence and prevalence
Mortality, DALYs and costs averted 
Fig. 1 Analytical framework of the model. Step 1, estimation of the
change in consumption and change in body weight resulting from
the SSB tax; Step 2, estimation of the changes in stroke incidence,
prevalence, mortality, costs saved and healthy years of life gained
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risk factor prevalence distribution and a relative risk func-
tion was used to calculate the PIF based on the age and
sex-specific changes in BMI distributions due to the 20 %
tax. We used relative risks of stroke from the GBD 2010
study [42]. The PIF estimates were then used to calculate
the changes in stroke incidence. Corresponding changes
in prevalence and mortality were calculated in the life
table model. Previously published estimates of baseline
stroke incidence, prevalence and case fatality rate for SA
were used [4]. Case fatality rate is defined as the annual
rate at which prevalent cases died. We also obtained from
the same study estimates of the proportion of stroke cases
that die within 28 days and incorporated these into the
model. The disease relative risk, incidence, prevalence and
case fatality rate estimates used in the model are presented
in Additional file 1: Table S2.
Health-adjusted life years and health care costs
The changes in stroke prevalence and mortality in the
intervention population influence total mortality rates
and the average health-related quality of life at each age
and sex, and therefore the total number of disability-
adjusted life years lived by the cohort. In the life table,
the populations are divided into 5-year cohorts and each
cohort is simulated until death or 100 years of age. Ad-
justments for time spent in poor health due to disease
or injury are made at each age based on prevalent life
years lived with disability (pYLD) derived from the 2010
GBD data for South Africa [43]. The health-adjusted
years of life gained due to the intervention are the differ-
ence in health-adjusted years of life lived between the
reference and intervention populations. Population
estimates by age and sex for 2012 were obtained from
Statistics South Africa. An average disability weight for
stroke of 0.28 was obtained from a previous study [4].
Unpublished all-cause mortality rates were obtained
from the SA Medical Research Council (MRC).
Using a health sector perspective, we estimated baseline
stroke health care costs using data from the South African
Government Employees Medical Scheme (GEMS). We
obtained data showing the average amount in South
African rands (ZAR) claimed for stroke per member in
2012 (unpublished data). We assumed the GEMS costs to
be private sector costs based on the fact that over 90 % of
medical aid members use private sector facilities. Under
the assumptions that 18 and 82 % of the South African
population uses private and public sector facilities respect-
ively [44] and, according to expert opinion, that public
sector costs are approximately 70 % of private sector costs,
we calculated weighted average costs of stroke in South
Africa. Neither the health care costs nor the DALYs were
discounted. The pYLD, health care costs and mortality
estimates used in the model are given in Additional file 1:
Table S3.
Uncertainty and sensitivity analysis
We estimated ninety-five percent uncertainty intervals
(UI) using Monte Carlo simulation using the Ersatz
programme (Barendregt JJ, Brisbane 2007), varying the
own and cross price elasticity estimates, the conversion
factor between energy consumption change and weight
change, the consumption estimates by age and sex for
all four beverages, and the relative risk estimates.
We performed deterministic sensitivity analysis to as-
sess the effect on the results of varying the tax rate
(10 %, 30 %), pass on rate, health care costs (10–20 % in-
crease and decrease), the pYLD estimates, BMI trend es-
timates, SSB portion size and the discounting rate. We
also tested the effect on the results of using the confi-
dence interval lower bound price elasticity estimate.
Results
Change in consumption, energy intake and BMI
The average baseline consumption of SSBs in 2012 was
184 ml per day [30]. The change in energy intake and
BMI resulting from the tax have been reported previ-
ously [30]. The average change in energy was 36 kJ per
person per day. Shifts in BMI were slightly greater in
women than men on average.
Change in the burden of stroke
Our model estimates that without the tax intervention,
there would be approximately 6 400 000 new adult
stroke cases over 20 years, compared to 6 300 000 cases
with the intervention. This translates to relative changes
of between 1.0 and 1.8 % (Table 1). The number of new
cases and relative changes would be higher in females
than males.
The health care costs that may potentially be saved are
substantial, with more gains being made early on.
Figure 2 presents the change in incidence and stroke-
related health care costs averted.
In year 20 of the intervention, a potential ZAR342 million
(USD27 million) (95 % UI: ZAR222–463 million, USD 18–
37 million) may be saved, compared to ZAR30 million
(USD2 million) (95 % UI: ZAR21–ZAR39 million,
USD1.7–3.1 million) in year one, for a total of over ZAR5
billion (USD 400 million) over the entire 20 year period
(95 % UI: ZAR3.7–7.2 billion, USD296–576 million).
The tax is predicted to reduce the number of prevalent
stroke cases in adults by approximately 13 000 (95 % UI: 8
400–17 000) by year 20. We estimate that over 72 000 deaths
may be averted by the tax over the same period (95 % UI: 51
000–98 000). Figure 3 shows the deaths and DALYs averted
compared to changes in prevalence over time.
The annual number of deaths stabilises over the
20 year period. The change in prevalent cases also shows
a similar trend. However, the gains in healthy years of life
consistently increase. The model estimates that about 550
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000 stroke-related DALYs will be averted over a 20 year
period (95 % UI: 361 000–767 000).
Sensitivity analysis
The results of the sensitivity analyses are shown in
Table 2.
A higher tax rate would result in higher gains with
diminishing returns across all parameters and a higher
discount rate would generate the opposite effect, as fu-
ture health gains are valued less. The effect of changing
the pYLD on the results is negligible. Incorporating an
upward BMI trend in the model would also lead to
greater gains. However, if manufacturers and retailers do
not pass on the full amount of the tax, the gains would
be less. Similarly, if purchasing behaviour is not strongly
influenced by the price increase (lower price elasticity)
then the effects of the tax would be lower.
Discussion
Our model predicts that an SSB tax may avert approxi-
mately 550 000 stroke-related DALYs, 72 000 deaths and
over ZAR5 billion, (USD400 million) in health care costs
over 20 years (USD296–576 million). The number of in-
cident stroke cases may be reduced by approximately 85
000 and prevalent cases by about 13 000 over 20 years.
The impact of taxing SSBs has been assessed for obes-
ity and diabetes but this is the first study to assess the
impact of an SSB tax on the burden of stroke. With the
announcement by the South African government to
introduce a 20 % SSB tax in April 2017 [45], this body of
work will be of use to the policy makers.
Taxing SSBs was predicted to reduce the number of
obese adults by over 220 000 in South Africa (20 % tax)
[30], 9 900 in Ireland (10 % tax) [29] and 180 000 in the
United Kingdom (20 % tax) [28]. A 20 % tax has been
projected to potentially reduce the prevalence of
Table 1 Percentage reduction in incident and prevalent stroke cases and mortality
Year Incidence Incidence Prevalence Prevalence Mortality Mortality
Male (%) Female (%) Male (%) Female (%) Male (%) Female (%)
1 1.14 1.80 0.25 0.39 0.77 1.24
(0.73–1.64) (1.20-2.50) (0.16–0.35) (0.26–0.53) (0.49–1.11) (0.82-1.73)
5 1.09 1.70 0.89 1.33 1.02 1.66
(0.69–1.65) 1.00–2.39) (0.59–1.30) (0.87–1.87) (0.65–1.52) (0.99–1.73)
10 1.06 1.67 1.02 1.50 1.08 1.74
(0.67–1.54) (1.07–2.52) (0.68–1.54) (0.99–2.10) (0.71–1.60) (1.11–2.51)
15 1.01 1.63 1.04 1.53 1.07 1.73
(0.64–1.33) (0.99–2.32) (0.70–1.50) (1.03–2.22) (0.71–1.60) (1.07–2.51)
20 1.01 1.67 1.03 1.55 1.07 1.76























































Change in incidence Costs averted
Fig. 2 Stroke-related health care costs averted and change in incident stroke cases over time (20 years). Left vertical axis, change in stroke incident
cases; right vertical axis, health care costs averted
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diabetes by 4.0 % in South Africa and by 1.6 % in India
[27, 46]. Our results show decreases in stroke prevalence
of between 0.32–1.31 % and compare well with the other
studies despite different impact sizes. Several reasons
may explain this difference in impact size of an SSB tax
on diabetes versus stroke. Firstly, the relative risk of
diabetes given increasing BMI is higher than for stroke.
Secondly, the comparisons are between different coun-
tries and differing BMI distributions and baseline preva-
lence rates of obesity play a role. It may be due to the
use of different methods in the studies and lastly, stroke
has a high 28 day mortality rate (accounted for in our
model) therefore only those who survive the first 28 days
can continue to benefit from the tax.
Study strengths and limitations
The strengths of our study include the use of South
African data for baseline consumption and BMI and
stroke health care costs, the use of price elasticities to
account for substitution to other drinks and modelling
the effect of the tax by sex over time. The pYLD esti-
mates from the GBD were also specific to South Africa.
We accounted for stroke cases that die within 28 days
using previously published data and therefore accounted
for these in the DALYs and mortality averted.
Our epidemiological and cost estimate inputs were
based on observational data which is subject to informa-
tion and selection bias. Measures were, however, taken
in the nationwide surveys from which we derived BMI
and consumption estimates. We also included these in
the Monte Carlo simulations or sensitivity analyses.
The price elasticity and relative risk estimates were
not specific to South Africa and we included these in the
Monte Carlo simulation for uncertainty. Previous studies
in the USA and Europe have also used similar price elas-
ticity estimates [25, 28, 29]. In India, a lower estimate
was used [27] and using a similar estimate would have
led to smaller changes in SSB consumption and reduced
changes in the obesity and stroke burden. Briggs et al.
[28] found that increasing the price of SSBs would in-
crease and not decrease the demand for diet drinks as
assumed in our model. However, since diet drinks are
designed to have low caloric content this would have
minimal impact on the model. Both the Indian and
British studies quoted above used smaller fruit juice
cross-price elasticities than our study.
We used proxy estimates for the health care costs of
stroke due to the unavailability of data and the effect of
variation in these data was tested in sensitivity analyses.
We did not account for costs that may result from other
diseases or senior care costs in the people who avoid
death from stroke due to the intervention. Also not
included in the analysis are potential costs of taxation.
Accounting for these may attenuate the gains in health
care costs.
The baseline consumption data were self-reported
which may have led to over- or underestimation of
consumption levels as shown by the sensitivity analysis
results for SSB portion size. It is possible that we under-
estimated the baseline disease parameters due to the
general paucity of data on stroke in South Africa [4, 5].
We did not model the direct impact of SSB consump-
tion on stroke nor the potential impact of the tax
through the mediation of other diseases like type 2 dia-
betes mellitus (T2DM) and heart disease and other risk
factors such as hypertension, which would add consider-
ably to the full impact of the tax given the increasing
burden of these conditions in South Africa. The CMS
reports an 85 % overall increase prevalence of T2DM be-
tween 2006 and 2011 in medical aid beneficiaries and
evidence also shows that the burden of hypertension is
increasing [4, 5, 44].
Due to unavailability of data, the model did not ac-


























































Change in prevalence Mortality averted Health-adjusted life years averted
Fig. 3 Change in prevalent stroke cases and annual deaths and health-adjusted life years averted over time (20 years). Left vertical axis, change in
prevalence and mortality averted over time; right vertical axis, health-adjusted life years averted
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such as coffee and tea, flavoured, sweetened milk or to
other sweetened foods. This may have potentially led to
under or overestimation of the impact of the tax, de-
pending on the size of the shift to the alternative drinks.
Other studies show that substitution to non-drink foods
does not significantly affect the results [47].
We assumed that the price elasticities would have the
same effect across different income groups. Evidence
from other studies suggests that the effect may be the
same, or demand may be reduced to a greater extent in
the lower income groups, while other studies found
lower demand only for particular categories of SSBs
[27–29, 47].
Some research suggests that increased BMI is associ-
ated with a decreased risk of mortality in stroke survi-
vors, the so-called “obesity paradox” [48, 49]. Not much
evidence is available on the mechanisms involved but
two plausible explanations for the obesity paradox may
be collider stratification bias when there is conditioning
on disease state in the analysis as well as reverse
Table 2 Sensitivity analysis of the effect on the outcome of variation in model parameters






Total stroke health care costs
over 20 years (billion ZAR)
Tax rate
10 % −50 457 321 750 −7 538 −3.0
20 % −85 766 546 762 −12 860 −5.1
30 % −109 435 706 570 −16 168 −6.6
Discount rate
0 % −85 766 546 762 −12 860 −5.1
1 % −87 824 494 539 −13 165 −4.8
2 % −88 646 441 074 −13 197 −4.3
3 % −89 648 397 838 −13 300 −4.0
SSB portion size
200 ml −19 395 129 488 −2 760 −1.0
250 ml −46 150 296 910 −6 882 −2.7
330 ml −85 766 546 762 −12 860 −5.1
500 ml −174 008 1 107 665 −26 115 −10.6
Health care costs
120 % −85 766 546 762 −12 860 −6.3
110 % −85 766 546 762 −12 860 −6.0
100 % −85 766 546 762 −12 860 −5.1
90 % −85 766 546 762 −12 860 −4.8
80 % −85 766 546 762 −12 860 −4.1
pYLD
100 % −85 766 546 762 −12 860 −5.1
105 % −85 766 556 926 −12 860 −5.1
110 % −85 766 541 548 −12 860 −5.1
BMI trend
0 −85 766 546 762 −12 860 −5.1
0.1 −99 427 622 762 −15 432 −5.8
0.2 −109 060 673 237 −17 269 −6.1
0.3 −113 568 707 078 −18 015 −6.3
Pass on rate
80 % −74 637 477 949 −11 146 −4.5
90 % −81 846 524 691 −12 198 −4.9
100 % −85 766 546 762 −12 860 −5.1
Lower own price elasticity (−0.85) −32 205 211 543 −4 686 −1.8
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causality bias [50, 51]. Accounting for the obesity para-
dox in our model would have attenuated the impact of
the tax.
Study implications
Stroke causes a high mortality and disability burden
with about 33 % of cases in South Africa dying within
the first 28 days, and more than 75 % dying within
4 years post-event (SSA) [2, 4]. Between 50–65 % of
survivors have some form of physical or cognitive dis-
ability [6]. Stroke is increasingly affecting those aged
60 years and younger [7]. This leads to loss of work
force and poor economic outcomes with the loss of
breadwinners, while on the other hand, the prognosis
of stroke is worsened by poor economic conditions.
Many patients present late and there is poor access to re-
habilitation services [2]. This situation demonstrates the
need to implement and leverage population-wide inter-
ventions such as fiscal or legislature measures to prevent
stroke and other NCDs [52].
Although the tax has the potential to be financially re-
gressive, it may potentially be more beneficial to lower
income groups in South Africa because of limited access
to quality health care. To the extent that low-income in-
dividuals are more price sensitive, they will be more
likely to reduce their intake of SSBs, and thus experience
greater health gain [26]. In Mexico reductions in pur-
chases of taxed SSBs were highest among households of
low socio-economic status [31].
An SSB tax would contribute to the multi-pronged ap-
proach on NCD prevention envisaged by the DOH [24].
Mandatory salt regulations were passed in South Africa
in 2013 and will take effect in 2016 [53]. These regula-
tions have been projected to prevent approximately 7
400 CVD deaths and 4 300 non-fatal strokes annually,
amounting to an annual cost saving of ZAR300 million
(USD 40 million) [54]. The modelled SSB tax would be
complementary to these regulations and result in greater
reduction of disability and death due to NCDs and
greater cost savings.
The tax has the potential to reduce the burden on the
health system. In South Africa, stroke accounts for 5 %
of all admissions and 10 % of bed occupancy in adult
medical wards [2]. In 2011, the annual cost of treating
stroke (excluding rehabilitation) was estimated at
ZAR13–16 billion (USD1.0–1.3 million) annually
amounting to ZAR16–20 billion in 2015 (USD1.3–1.6
million) [4]. With a total health budget allocation of
ZAR157.3 billion in 2015 in South Africa [55], the cost
of treating stroke would consume approximately 10–
13 % of the budget. Our results estimate a saving of
approximately ZAR5 billion over 20 years. Together
with other interventions, this would make a significant
difference to the health system.
The tax could potentially raise substantial revenue.
Preliminary calculations done at PRICELESS-SA,
Johannesburg, South Africa, indicate that approximately
ZAR7 billion may potentially be raised every year from an
SSB tax (unpublished data). Although currently in South
Africa tax revenue is not earmarked [56], it can contribute
to the national health budget.
The informal and indirect costs of disease are often
overlooked. Stroke survivors depend on family and com-
munity for support for activities of daily living (ADL)
which in turn impacts on their quality of life [6]. Our
model did not incorporate these costs and so potentially
underestimated the resources that may be saved by the
tax. Reducing stroke frequency by preventive measures,
as well as reducing stroke mortality and long-term dis-
ability by evidence-based acute and post-discharge treat-
ments, is essential to avoid the trend of increase in the
stroke burden [6].
An increased SSB price conveys a message that SSBs
are unhealthy and are therefore being taxed. This public
health message would also contribute to the creation of
enabling environment for making better dietary choices.
Conclusions
Fiscal policy has the potential to mitigate the growing
burden of stroke in South Africa and contribute to the
achievement of one of the targets set by the South
African government to reduce relative premature mor-
tality (less than 60 years) from NCDs by 2020 [24]. The
South African government announced plans in February
2016 to introduce a 20 % SSB tax in April 2017 [45]. If
implemented as part of a multi-faceted strategy, this far-
sighted approach may have a direct impact on obesity
and on reducing associated NCDs such as stroke.
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